Developer docs
API playgroundTry for free, no card

Search company profiles

Copea Pharma

Full company profile

uuid002x26d

Namestring
Copea Pharma
Legal namestring
Copea Pharmaceutical
Websiteurl
copeapharma.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Copea Pharma (legal entity: Copea Pharmaceutical) is a UK-based contract pharmaceutical organisation headquartered in Liverpool that provides independent Qualified Person (QP) services to pharmaceutical companies. Founded in 2013 and operating with 11-50 employees, the company holds four MHRA licences — Wholesale Dealer WDA(h), Manufacturing/Importation Authorisation (MIA), MIA (IMP) for Investigative Medicinal Products, and a Specials licence for unlicensed medicines — which together authorise it to perform importation, bulk and finished product certification, secondary packaging, and distribution of clinical, commercial, and named-patient medicinal products. Its QPs cover a broad dosage-form portfolio spanning aseptics, terminally sterilised products, oral solids, creams, ointments, liquids, transdermal patches, granules, powders, radiopharmaceuticals, biologicals, biotechnology, and inhaled formulations, enabling engagement across heterogeneous clinical and commercial projects.

Operationally, Copea runs MHRA-approved warehouses at its Liverpool site (25 Compass West, L24 1YA) with ambient storage at 15-25°C and cold-chain storage at 2-8°C, supported by 24/7 electronic alarm monitoring and cold-chain redundancy. Its service catalogue is organised around five pillars: QP Project Services (importation, certification, audits, QMS review, inspection readiness), Clinical Trials Services (secondary labelling, comparator and auxiliary medicine sourcing, JIT labelling, multi-language patient kits), Commercial Services (pack manipulation, QP certification on EU entry, importation testing management), Unlicensed Medicines / named-patient supply, and Facilities (storage and secondary packaging). Distribution extends to the EU, US, and Rest of World.

The business model is B2B professional services on a project-based, quote-driven fee structure with no publicly disclosed pricing. Go-to-market is sales-led and direct, with the assigned QP acting as the primary point of contact for each sponsor project. The company reports no public ownership structure, no funding rounds, no M&A activity, and no disclosed revenue or headcount trend, and serves an unspecified roster of pharmaceutical company clients across multiple regulatory jurisdictions.

Short descriptiontext

Copea Pharma is a UK-based MHRA-licensed contract organisation providing independent Qualified Person certification, importation, and packaging services for clinical, commercial, and unlicensed pharmaceutical products. It serves pharmaceutical sponsors through project-based B2B engagements from its Liverpool warehouse facility.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLiverpool, United Kingdom
HQ citystring
Liverpool
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Qualified Person services, pharmaceutical importation, clinical trial labelling, cold chain storage, regulatory compliance audits
Industry5 codes
PRIMARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLACAMAD
Pharma & Life Sciences Cold Chain Forwarding (GDP-Compliant)
SECONDARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Packaging and Labeling Services56191
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Contract Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1QP Project Services
TypeProfessional Services
Description

Contract organization providing independent Qualified Person services for pharmaceutical companies. Services include importation, bulk certification, finished product certification, audits, project management, QMS review, self inspection programmes, and inspection readiness preparation. Revenue is generated through project-based professional service fees.

copeapharma.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Copea Pharma is a UK-based contract organization providing independent Qualified Person (QP) services to pharmaceutical companies. Core offerings include QP certification for imported bulk and finished products (clinical and commercial), importation of clinical, commercial, and unlicensed medicinal products, secondary packaging and multi-language labelling, MHRA-approved temperature-controlled storage (15-25°C and 2-8°C), audits, QMS review, and inspection readiness preparation. All services are delivered under MHRA licences (WDA(h), MIA, MIA IMP, Specials) from its Liverpool facility.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Ensures smooth transition of projects to certification stage without last-minute regulatory roadblocks
+1 more record
Product overview1 text field

Copea Pharma is a contract pharmaceutical organization specializing in independent Qualified Person (QP) services. The company operates as a single unified service offering with interconnected capabilities rather than a platform-plus-modules architecture. The core QP Project Services encompass importation, bulk certification, and finished product certification for clinical and commercial products. Clinical Trials Services provide secondary labelling, comparator sourcing, and JIT labelling support. Commercial Services handle pack manipulation and importation testing. Unlicensed Medicines Services manage named patient supply. Facilities include MHRA-approved warehouses for storage (ambient and cold chain) and secondary packaging. All services are underpinned by MHRA licenses including Wholesale Dealer WDA(h), MIA, MIA (IMP), and Specials licenses.

Product and service5 records
1QP Project Services
CategoryQualified Person (QP) Services
Description

Comprehensive Qualified Person services for pharmaceutical companies covering importation, bulk certification, finished product certification, audits, project management, QMS review, self-inspection programmes, and inspection readiness preparation for clinical and commercial medicinal products.

2Clinical Trials Services
CategoryClinical Trial Supply Services
Description

End-to-end clinical trial support including secondary labelling, QP certification, comparator and auxiliary medicine sourcing, JIT labelling, and distribution to the EU, US, and Rest of World markets for pharmaceutical companies running clinical trials.

3Commercial Services
CategoryCommercial Product Services
Description

Commercial medicinal product support including pack manipulation, QP certification upon EU entry, and importation testing management (analytical chemistry or microbiological) for pharmaceutical companies commercialising products in the EU.

4Unlicensed Medicines Services
CategoryUnlicensed Medicines Supply
Description

Named patient supply services for unlicensed medicines imported into the UK to meet unmet clinical needs, including bona fide checks and regulatory documentation management for pharmaceutical companies and prescribers.

5Facilities - Storage & Packaging
CategoryPharmaceutical Warehousing and Packaging
Description

MHRA-approved warehouse facilities providing secondary packaging and labelling of clinical trial and commercial products, ambient storage (15-25°C), cold chain storage (2-8°C), and distribution capabilities serving the EU, US, and Rest of World.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Northern Ireland-headquartered pharma services group offering QP services, clinical trial packaging, commercial packaging, and temperature-controlled storage. Closest direct UK/UK-adjacent incumbent with overlapping IMP packaging, QP certification, and multi-language labelling capabilities.

2Recipharm
TypeBroad incumbent
Description

European CDMO offering QP certification, packaging, and supply chain services as part of a broader development and manufacturing portfolio. Comparable where sponsors require QP-led release for commercial and clinical products.

TypeDirect peer
Description

UK-based pharmaceutical contract services provider specialising in clinical and commercial packaging, QP release, MHRA-licensed storage, and Specials/named patient supply — closely mirroring Copea's combined IMP, commercial, and Specials licence footprint.

TypeDirect peer
Description

Global contract provider of clinical and commercial packaging, labelling, storage, and distribution for pharmaceuticals. Direct peer given shared focus on multi-language clinical trial labelling, cold-chain storage, and QP-led importation support.

5Sharp Clinical Services
TypeDirect peer
Description

Clinical trials packaging, labelling, and distribution specialist with comparator sourcing and QP-aligned services. Highly comparable to Copea's clinical trials service line in scope, customer base, and regulatory positioning.

TypeBroad incumbent
Description

CDMO offering drug development, manufacturing, and QP-aligned services including clinical and commercial supply. Comparable at the QP certification and importation release stage of the pharmaceutical supply chain.

TypeBroad incumbent
Description

Large global CDMO with clinical supply services including packaging, labelling, comparator sourcing, and QP release. Competes for the same clinical trial material workflow business as Copea, with much greater scale.

TypeBroad incumbent
Description

Global pharma services network including clinical packaging, QP services, and distribution via its Patheon footprint. Represents a large, full-service competitor that frequently wins contracts that smaller QP specialists would otherwise pursue.

TypeBroad incumbent
Description

UK-based pharmaceutical contract development and manufacturing organisation providing commercial and clinical supply services including QP release. Direct UK peer with overlapping regulated supply chain capabilities.

TypeEmerging player
Description

Provides embedded QP and quality professionals to pharmaceutical companies, partially overlapping with Copea's QP and audit service lines. Comparable as a competitor for outsourced QP resource contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Copea Pharma

Pharmaceutical Contract Servicescopeapharma.com

Copea Pharma is a UK-based MHRA-licensed contract organisation providing independent Qualified Person certification, importation, and packaging services for clinical, commercial, and unlicensed pharmaceutical products. It serves pharmaceutical sponsors through project-based B2B engagements from its Liverpool warehouse facility.

What Copea Pharma does

Copea Pharma (legal entity: Copea Pharmaceutical) is a UK-based contract pharmaceutical organisation headquartered in Liverpool that provides independent Qualified Person (QP) services to pharmaceutical companies. Founded in 2013 and operating with 11-50 employees, the company holds four MHRA licences — Wholesale Dealer WDA(h), Manufacturing/Importation Authorisation (MIA), MIA (IMP) for Investigative Medicinal Products, and a Specials licence for unlicensed medicines — which together authorise it to perform importation, bulk and finished product certification, secondary packaging, and distribution of clinical, commercial, and named-patient medicinal products. Its QPs cover a broad dosage-form portfolio spanning aseptics, terminally sterilised products, oral solids, creams, ointments, liquids, transdermal patches, granules, powders, radiopharmaceuticals, biologicals, biotechnology, and inhaled formulations, enabling engagement across heterogeneous clinical and commercial projects.

Operationally, Copea runs MHRA-approved warehouses at its Liverpool site (25 Compass West, L24 1YA) with ambient storage at 15-25°C and cold-chain storage at 2-8°C, supported by 24/7 electronic alarm monitoring and cold-chain redundancy. Its service catalogue is organised around five pillars: QP Project Services (importation, certification, audits, QMS review, inspection readiness), Clinical Trials Services (secondary labelling, comparator and auxiliary medicine sourcing, JIT labelling, multi-language patient kits), Commercial Services (pack manipulation, QP certification on EU entry, importation testing management), Unlicensed Medicines / named-patient supply, and Facilities (storage and secondary packaging). Distribution extends to the EU, US, and Rest of World.

The business model is B2B professional services on a project-based, quote-driven fee structure with no publicly disclosed pricing. Go-to-market is sales-led and direct, with the assigned QP acting as the primary point of contact for each sponsor project. The company reports no public ownership structure, no funding rounds, no M&A activity, and no disclosed revenue or headcount trend, and serves an unspecified roster of pharmaceutical company clients across multiple regulatory jurisdictions.

Copea Pharma firmographics

Firmographics
Name
Copea Pharma
Legal name
Copea Pharmaceutical
Website
https://copeapharma.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Copea Pharma is a UK-based MHRA-licensed contract organisation providing independent Qualified Person certification, importation, and packaging services for clinical, commercial, and unlicensed pharmaceutical products. It serves pharmaceutical sponsors through project-based B2B engagements from its Liverpool warehouse facility.
Ownership category
akta.pro rank

Copea Pharma industry classification

Industry
Product category
Pharmaceutical Contract Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Packaging and Labeling Services (56191)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAC
Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYTLACAMAD
Pharma & Life Sciences Cold Chain Forwarding (GDP-Compliant)
SECONDARYTLAIAGAI
Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)

Keywords

  • Qualified Person services
  • Pharmaceutical importation
  • Clinical trial labelling
  • Cold chain storage
  • Regulatory compliance audits

Where Copea Pharma is headquartered

Location

Headquarters

HQ city
Liverpool
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Copea Pharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Others

Revenue model

  1. QP Project Services: Contract organization providing independent Qualified Person services for pharmaceutical companies. Services include importation, bulk certification, finished product certification, audits, project management, QMS review, self inspection programmes, and inspection readiness preparation. Revenue is generated through project-based professional service fees.

Go-to-market motion1 record

Distribution channels1 record

Copea Pharma product offering

Product offering

Core offering

Copea Pharma is a UK-based contract organization providing independent Qualified Person (QP) services to pharmaceutical companies. Core offerings include QP certification for imported bulk and finished products (clinical and commercial), importation of clinical, commercial, and unlicensed medicinal products, secondary packaging and multi-language labelling, MHRA-approved temperature-controlled storage (15-25°C and 2-8°C), audits, QMS review, and inspection readiness preparation. All services are delivered under MHRA licences (WDA(h), MIA, MIA IMP, Specials) from its Liverpool facility.

Product overview

Copea Pharma is a contract pharmaceutical organization specializing in independent Qualified Person (QP) services. The company operates as a single unified service offering with interconnected capabilities rather than a platform-plus-modules architecture. The core QP Project Services encompass importation, bulk certification, and finished product certification for clinical and commercial products. Clinical Trials Services provide secondary labelling, comparator sourcing, and JIT labelling support. Commercial Services handle pack manipulation and importation testing. Unlicensed Medicines Services manage named patient supply. Facilities include MHRA-approved warehouses for storage (ambient and cold chain) and secondary packaging. All services are underpinned by MHRA licenses including Wholesale Dealer WDA(h), MIA, MIA (IMP), and Specials licenses.

Differentiator

Problem solved

Functional benefit

Products and services

  • QP Project Services Comprehensive Qualified Person services for pharmaceutical companies covering importation, bulk certification, finished product certification, audits, project management, QMS review, self-inspection programmes, and inspection readiness preparation for clinical and commercial medicinal products.
  • Clinical Trials Services End-to-end clinical trial support including secondary labelling, QP certification, comparator and auxiliary medicine sourcing, JIT labelling, and distribution to the EU, US, and Rest of World markets for pharmaceutical companies running clinical trials.
  • Commercial Services Commercial medicinal product support including pack manipulation, QP certification upon EU entry, and importation testing management (analytical chemistry or microbiological) for pharmaceutical companies commercialising products in the EU.
  • Unlicensed Medicines Services Named patient supply services for unlicensed medicines imported into the UK to meet unmet clinical needs, including bona fide checks and regulatory documentation management for pharmaceutical companies and prescribers.
  • Facilities - Storage & Packaging MHRA-approved warehouse facilities providing secondary packaging and labelling of clinical trial and commercial products, ambient storage (15-25°C), cold chain storage (2-8°C), and distribution capabilities serving the EU, US, and Rest of World.

Quantifiable outcome

  • Ensures smooth transition of projects to certification stage without last-minute regulatory roadblocks
  • +1 more outcomes

Companies that use Copea Pharma

Customer profile

Segments1 record

Ideal customer profiles1 record

Copea Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Copea Pharma partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Copea Pharma competitors and assessment

Company assessment

Broad incumbents

  • Almac Group: Northern Ireland-headquartered pharma services group offering QP services, clinical trial packaging, commercial packaging, and temperature-controlled storage. Closest direct UK/UK-adjacent incumbent with overlapping IMP packaging, QP certification, and multi-language labelling capabilities.
  • Recipharm: European CDMO offering QP certification, packaging, and supply chain services as part of a broader development and manufacturing portfolio. Comparable where sponsors require QP-led release for commercial and clinical products.
  • Piramal Pharma Solutions: CDMO offering drug development, manufacturing, and QP-aligned services including clinical and commercial supply. Comparable at the QP certification and importation release stage of the pharmaceutical supply chain.
  • Catalent: Large global CDMO with clinical supply services including packaging, labelling, comparator sourcing, and QP release. Competes for the same clinical trial material workflow business as Copea, with much greater scale.
  • Thermo Fisher Scientific (Patheon): Global pharma services network including clinical packaging, QP services, and distribution via its Patheon footprint. Represents a large, full-service competitor that frequently wins contracts that smaller QP specialists would otherwise pursue.
  • Aesica Pharmaceuticals (Consort Medical): UK-based pharmaceutical contract development and manufacturing organisation providing commercial and clinical supply services including QP release. Direct UK peer with overlapping regulated supply chain capabilities.

Direct peers

  • Wasdell Group: UK-based pharmaceutical contract services provider specialising in clinical and commercial packaging, QP release, MHRA-licensed storage, and Specials/named patient supply — closely mirroring Copea's combined IMP, commercial, and Specials licence footprint.
  • PCI Pharma Services: Global contract provider of clinical and commercial packaging, labelling, storage, and distribution for pharmaceuticals. Direct peer given shared focus on multi-language clinical trial labelling, cold-chain storage, and QP-led importation support.
  • Sharp Clinical Services: Clinical trials packaging, labelling, and distribution specialist with comparator sourcing and QP-aligned services. Highly comparable to Copea's clinical trials service line in scope, customer base, and regulatory positioning.

Emerging players

  • Eurofins PSS Insourcing Solutions: Provides embedded QP and quality professionals to pharmaceutical companies, partially overlapping with Copea's QP and audit service lines. Comparable as a competitor for outsourced QP resource contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Copea Pharma social profiles

Digital presence

Copea Pharma compliance and trust

Trust signal

Compliance6 records

Copea Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Copea Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Copea Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Copea Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Copea Pharma

What does Copea Pharma do?

Copea Pharma is a UK-based contract organization providing independent Qualified Person (QP) services to pharmaceutical companies. Core offerings include QP certification for imported bulk and finished products (clinical and commercial), importation of clinical, commercial, and unlicensed medicinal products, secondary packaging and multi-language labelling, MHRA-approved temperature-controlled storage (15-25°C and 2-8°C), audits, QMS review, and inspection readiness preparation. All services are delivered under MHRA licences (WDA(h), MIA, MIA IMP, Specials) from its Liverpool facility.

Is Copea Pharma a public or private company?

Copea Pharma is a private company. It is classified as unknown and is currently operating.

When was Copea Pharma founded?

Copea Pharma was founded in 2013. It employs 1 to 10 people.

Where is Copea Pharma based?

Copea Pharma is headquartered in Liverpool, United Kingdom, in the Europe region.

How does Copea Pharma make money?

One revenue line is on record: QP Project Services.

Who are Copea Pharma's main competitors?

Broad incumbents on record are Almac Group, Recipharm, Piramal Pharma Solutions, Catalent, Thermo Fisher Scientific (Patheon) and Aesica Pharmaceuticals (Consort Medical). Direct peers are Wasdell Group, PCI Pharma Services and Sharp Clinical Services. Eurofins PSS Insourcing Solutions is listed as an emerging player.

Does Copea Pharma have an API?

No public API is recorded for Copea Pharma.

What industry is Copea Pharma in?

Copea Pharma's product category is Pharmaceutical Contract Services. Its primary akta.pro industry code is HLAIAJAL, Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals, with a secondary code of HLAGAMAC, Clinical Trial Logistics & Depot Services (IRT-integrated, kitting, returns). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales